Dr Agarwals Healthcare IPO is a book-built issue amounting to Rs 3,027.26 crores, comprising a fresh issue of 0.75 crore shares totaling Rs 300.00 crores and an offer for sale of 6.78 crore shares aggregating to Rs 2,727.26 crores.
The subscription for the Dr Agarwals Healthcare IPO opens on January 29, 2025, and closes on January 31, 2025. The allotment process is expected to be finalized on Monday, February 3, 2025. The IPO is scheduled to list on the BSE and NSE, with a tentative listing date set for Wednesday, February 5, 2025.
Dr Agarwal’s Health Care operates in the eye care sector. They provide a range of services including cataract, refractive surgeries, glaucoma treatment, retina services, and optical products such as glasses and contact lenses.
The price band for the Dr Agarwals Healthcare IPO has been fixed between ₹382 and ₹402 per share. The minimum lot size for an application is 35 shares. Retail investors are required to invest a minimum of ₹14,070, while small non-institutional investors (sNII) must apply for at least 15 lots (525 shares), amounting to ₹2,11,050. For big non-institutional investors (bNII), the minimum lot size investment is 72 lots (2,520 shares), amounting to ₹10,13,040.
Kotak Mahindra Capital Company Limited, Morgan Stanley India Company Pvt Ltd, Jefferies India Private Limited, and Motilal Oswal Investment Advisors Limited are the book-running lead managers for the Dr Agarwals Healthcare IPO, with Kfin Technologies Limited serving as the registrar for the issue.
Dr Agarwals Healthcare IPO Details:
Company Name | Dr Agarwals Healthcare Limited |
Sector | Eye Care |
IPO Type | Mainboard |
IPO Open date | 29th Jan 2025 |
IPO Close date | 31st Jan 2025 |
Listing Exchanges | NSE, BSE |
DRHP Draft Prospectus | Click to check |
RHP Draft Prospects | Click to check |
Dr Agarwals Healthcare IPO Lot Size:
Application | Lot Size | Shares | Amount |
Retail (Min) | 1 | 35 | 14,070 |
sHNI (Min) | 15 | 525 | 2,11,050 |
bHNI (Min) | 72 | 2520 | 10,13,040 |
Dr Agarwals Healthcare IPO Timeline:
IPO Open Date | 29th Jan 2025 |
IPO Close Date | 31st Jan 2025 |
Basis of Allotment | 03rd Feb 2025 |
Refund Initiation Date | 04th Feb 2025 |
Shares Credit to Demat | 04th Feb 2025 |
Listing Date | 05th Feb 2025 |
Things to Consider before applying for an IPO
Financial Performance: Review Dr Agarwals Healthcare’s Financials to understand its revenue, profitability, and growth prospects.
Industry Outlook: Consider the overall health of India’s Eye Care Industry.
Valuation: Compare the price band to similar companies in the industry to see if the IPO is priced fairly.
Management Team: Research the experience and capabilities of the management team.
Our Verdict
This IPO offers a good opportunity to invest in Dr Agarwals Healthcare and be a part of its growth.
FAQ
What is Grey Market Premium (GMP)?
The Grey Market Premium (GMP) represents the price at which an Initial Public Offering (IPO) is traded in the unregulated grey market before its official listing. It serves as an indicator of how the IPO might perform on the listing day. Seeing the latest GMP, investors can estimate the listing performance of the IPO.